Stuart Shanler

2017

In 2017, Stuart Shanler earned a total compensation of $534.1K as Chief Scientific Officer at Aclaris Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$142,642
Salary$380,000
Other$11,436
Total$534,078

Shanler received $380K in salary, accounting for 71% of the total pay in 2017.

Shanler also received $142.6K in non-equity incentive plan and $11.4K in other compensation.

Rankings

In 2017, Stuart Shanler's compensation ranked 11,621st out of 14,666 executives tracked by ExecPay. In other words, Shanler earned more than 20.8% of executives.

ClassificationRankingPercentile
All
11,621
out of 14,666
21st
Division
Manufacturing
4,561
out of 5,772
21st
Major group
Chemicals And Allied Products
1,667
out of 2,075
20th
Industry group
Drugs
1,379
out of 1,731
20th
Industry
Pharmaceutical Preparations
1,076
out of 1,333
19th
Source: SEC filing on April 26, 2018.

Shanler's colleagues

We found two more compensation records of executives who worked with Stuart Shanler at Aclaris Therapeutics in 2017.

2017

Neal Walker

Aclaris Therapeutics

Chief Executive Officer

2017

Christopher Powala

Aclaris Therapeutics

Chief Regulatory and Development Officer

News

You may also like